NCT04264325View on ClinicalTrials.gov

Quantitative Diaphragmatic Ultrasound Evaluation in Pleural Effusions : A Feasability Study

CompletedOBSERVATIONAL
Enrollment

15

Participants

Timeline

Start Date

January 31, 2020

Primary Completion Date

August 20, 2020

Study Completion Date

May 3, 2023

Conditions
Malignant Pleural EffusionLung Neoplasms
Interventions
OTHER

diaphragmatic ultrasound measure

patients with lung neoplasms and malignant pleural effusions who need a diagnostic or therapeutic thoracocentesis

Trial Locations (1)

67091

Les Hôpitaux Universitaires de Strasbourg, Strasbourg

All Listed Sponsors
lead

University Hospital, Strasbourg, France

OTHER

NCT04264325 - Quantitative Diaphragmatic Ultrasound Evaluation in Pleural Effusions : A Feasability Study | Biotech Hunter | Biotech Hunter